Measles Vaccine
Economic analysis of mass measles vaccination in South Africa reported
Published in Vaccine Weekly, November 24th, 2004
"To evaluate economic implications of conducting a 'catch-up' measles vaccination campaign, we conducted an economic analysis of the 1996-1997 measles immunization campaign in two provinces of South Africa comparing the baseline two-dose routine immunization program to the combined vaccination strategy (routine two-dose immunization program, plus the 1996-1997 campaign)," scientists in the United States and South Africa report.
"The study findings indicate that the 1996-1997 mass measles immunization campaign was cost-effective in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2004-11-24)
More Articles from Vaccine Weekly
- AIDS/HIV Vaccine
Parenteral vaccine adjuvants promote mucosal anti-HIV immune responses - Anthrax Vaccine
Anthrax proteins associated with germination and outgrowth identified - Cancer Vaccine
Heat shock protein gp96 elicits anti-tumor CD8 T cell cytotoxicity - Meningococcal Vaccine
Putative vaccine antigens from Neisseria meningitidis identified - Nicotine Vaccine
Riboflavin used for antibody-catalyzed oxidation of nicotine - AIDS/HIV Vaccine
DNA vaccine elicits efficient CD8+ T cell response to HIV epitope - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
